KRAS G12C Lung Cancer - Advanced Non-Small Cell Lung Cancer, KRAS G12C Positive - Pemetrexed | Clinical Trial Radar | Chugai Pharmaceutical

Powered by Trial Radar

Advanced

Trial Radar AI Trial Candidate or Patient Patient Caregiver Healthcare Pro Biotech Pro Biotech Investor Researcher Other
	Let's discuss and explore clinical trials with Chugai Pharmaceutical as a lead sponsor or collaborator. Showing clinical trials for KRAS G12C Lung Cancer. I can help you find nearby clinical trials and understand health conditions and treatments.

Search by location, facility...

Search by keywords...

Study Title	Status
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer (Krascendo 2) NCT06793215	Recruiting